A complex manufacturing process

The active pharmaceutical ingredient (API) in our products is derived from crude fish oil and manufactured through a complex process in compliance with good manufacturing practices. Production takes place at our state of the art production facility in Sandefjord, Norway.

The API is the result of a highly purified pharmaceutical preparation of EPA and DHA ethyl esters, a chemically modified form of fatty acids. The manufacturing processes include proprietary steps producing a patented product containing a total concentration of above 90 per cent omega-3 ethyl esters.

Deacidification/alkaline refining
This step refines the crude oil by removing free fatty acids and impurities.

Stripping
The stripping step is a highly specialised process whereby the environmental pollutants and cholesterol are removed from the refined fish oil.

Ethyl transesterification
In this step, the triglycerides of the deacidified and stripped fish oil react to form ethyl esters.

Distillation
An evaporation and condensation process that occurs at extremely low
pressure to increase the omega-3 concentration.

Precipitation
A complex precipitation step is used to increase the concentration of omega-3 fatty acid ethyl esters. Oxidation compounds and environmental pollutants are then removed and an antioxidant added to produce the final API.